The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...
Chronic inflammation in the brain is the major cause of dementia. Oleocanthal is a natural anti-inflammatory agent found in ...
FDA approves Symbravo for acute migraine relief, combining rizatriptan and meloxicam. Discover its unique benefits and fast ...
Amir Anwary is a vet who's known for sharing pet advice online. He recently warned people that four common items are toxic to ...
A vet has issued a warning to cat owners about some of the household items that can be toxic to their pets, including a ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
Vertex Pharmaceuticals Inc. (VRTX) has secured FDA approval for Suzetrigine, an oral, non-opioid, highly selective NaV1.8 pain signal ...
"There's different kinds of pain, just like we know in humans," explains Dr. Jerry Klein, a chief veterinary officer at the ...
The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
A pet owner's home is a haven for their furry friends, but there could be some risks hiding in plain sight. A vet has ...
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.